GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissectionsfor Aortic DissectionSites in Milwaukee +21 more locationsSponsor: W.L.Gore & AssociatesSex: All·Age: 18+Code: NCT06827990·Recruiting·Listed Feb 2025Apply to this trial
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.for Lung Cancer (Diagnosis)Sites in Milwaukee +10 more locationsSponsor: bioAffinity Technologies Inc.Sex: All·Age: 50 - 80Code: NCT07168993·Recruiting·Listed Sep 2025Apply to this trial
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumorsfor Metastatic Solid TumorSites in Milwaukee +15 more locationsSponsor: Eli Lilly and CompanySex: All·Age: 18+Code: NCT06561685·Phase 1·Recruiting·Listed Aug 2024Apply to this trial
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)for Relapsed or Refractory Multiple Myeloma (RRMM)Sites in Milwaukee +16 more locationsSponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanySex: All·Age: 18+Code: NCT06615479·Phase 3·Recruiting·Listed Sep 2024Apply to this trial
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancerfor Ovarian CancerSites in Milwaukee, Madison +19 more locationsSponsor: Regeneron PharmaceuticalsSex: Female·Age: 18+Code: NCT06787612·Phase 2·Recruiting·Listed Jan 2025Apply to this trial
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasmsfor Myeloproliferative NeoplasmsSites in Milwaukee +11 more locationsSponsor: Incyte CorporationSex: All·Age: 18+Code: NCT07008118·Phase 1·Recruiting·Listed Jun 2025Apply to this trial
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myelomafor Relapsed/Refractory Multiple MyelomaDrug: DaratumumabSites in Milwaukee, Madison +13 more locationsSponsor: BeOne MedicinesSex: All·Age: 18+Code: NCT04973605·Phase 1, Phase 2·Recruiting·Listed Jul 2021Apply to this trial
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignanciesfor B-cell MalignancySites in Milwaukee, Madison +16 more locationsSponsor: BeOne MedicinesSex: All·Age: 18+Code: NCT06634589·Phase 1, Phase 2·Recruiting·Listed Oct 2024Apply to this trial
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)for Treatment Resistant DepressionSites in Milwaukee +23 more locationsSponsor: Abbott Medical DevicesSex: All·Age: 22 - 70Code: NCT06423430·Recruiting·Listed May 2024Apply to this trial
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancerfor Metastatic Castration-resistant Prostate CancerSites in Milwaukee +22 more locationsSponsor: Syncromune, Inc.Sex: Male·Age: 18+Code: NCT06533644·Phase 2·Recruiting·Listed Aug 2024Apply to this trial
XTX301 in Patients With Advanced Solid Tumorsfor Advanced Solid TumorSites in Milwaukee +9 more locationsSponsor: Xilio Development, Inc.Sex: All·Age: 18+Code: NCT05684965·Phase 1, Phase 2·Recruiting·Listed Jan 2023Apply to this trial
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Kneefor Chondral DefectSites in Milwaukee +10 more locationsSponsor: Vericel CorporationSex: All·Age: 10 - 17Code: NCT03588975·Phase 3·Recruiting·Listed Jul 2018Apply to this trial
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemiafor MyelofibrosisSites in Milwaukee +23 more locationsSponsor: Disc Medicine, IncSex: All·Age: 18+Code: NCT05320198·Phase 1, Phase 2·Recruiting·Listed Apr 2022Apply to this trial
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignanciesfor Chronic Lymphocytic Leukemia (CLL)Sites in Milwaukee +14 more locationsSponsor: Nurix Therapeutics, Inc.Sex: All·Age: 18+Code: NCT05131022·Phase 1·Recruiting·Listed Nov 2021Apply to this trial
A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)for Carcinoma, Non-Small-Cell LungDrug: NavlimetostatSites in Milwaukee +11 more locationsSponsor: Bristol-Myers SquibbSex: All·Age: 18+Code: NCT06855771·Phase 2·Recruiting·Listed Mar 2025Apply to this trial
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPDfor COPDSites in Milwaukee +9 more locationsSponsor: Nuvaira, Inc.Sex: All·Age: 40 - 80Code: NCT07051707·Recruiting·Listed Jul 2025Apply to this trial
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancerfor Metastatic Castration-resistant Prostate CancerSites in Milwaukee +12 more locationsSponsor: Regeneron PharmaceuticalsSex: Male·Age: 18+Code: NCT05125016·Phase 1, Phase 2·Recruiting·Listed Nov 2021Apply to this trial
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3for COPDSites in Milwaukee +17 more locationsSponsor: Apreo Health, Inc.Sex: All·Age: 40 - 84Code: NCT06891755·Recruiting·Listed Mar 2025Apply to this trial
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosisfor Multiple Sclerosis, Relapsing-RemittingSites in Milwaukee +8 more locationsSponsor: Bristol-Myers SquibbSex: All·Age: 10 - 17Code: NCT06408259·Phase 3·Recruiting·Listed May 2024Apply to this trial
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)for Phenylketonuria (PKU)Drug: PalynziqSites in Milwaukee +11 more locationsSponsor: BioMarin PharmaceuticalSex: All·Age: All agesCode: NCT05813678·Recruiting·Listed Apr 2023Apply to this trial
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinibfor Chronic Lymphocytic LeukemiaSites in Milwaukee +19 more locationsSponsor: Eli Lilly and CompanySex: All·Age: 18+Code: NCT06876649·Phase 4·Recruiting·Listed Mar 2025Apply to this trial
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphomafor Chronic Lymphocytic LeukemiaSites in Milwaukee +15 more locationsSponsor: Eli Lilly and CompanySex: All·Age: 18+Code: NCT06876662·Phase 4·Recruiting·Listed Mar 2025Apply to this trial
Study of SGR-1505 in Mature B-Cell Neoplasmsfor Mature B-Cell NeoplasmSites in Milwaukee +15 more locationsSponsor: Schrödinger, Inc.Sex: All·Age: 18+Code: NCT05544019·Phase 1·Recruiting·Listed Sep 2022Apply to this trial
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)for Epilepsy, Temporal LobeSites in Milwaukee +15 more locationsSponsor: Neurona TherapeuticsSex: All·Age: 18 - 75Code: NCT06422923·Phase 1, Phase 2·Recruiting·Listed May 2024Apply to this trial
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)for Non-Hodgkin LymphomaSites in Milwaukee +9 more locationsSponsor: Imugene LimitedSex: All·Age: 18+Code: NCT03666000·Phase 1·Recruiting·Listed Sep 2018Apply to this trial
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infectionfor Viral PneumoniaSites in Milwaukee +21 more locationsSponsor: Synairgen Research Ltd.Sex: All·Age: 18+Code: NCT06999603·Phase 2·Recruiting·Listed May 2025Apply to this trial
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemiafor Chronic Lymphocytic LeukemiaDrug: SonrotoclaxSites in Milwaukee +12 more locationsSponsor: BeOne MedicinesSex: All·Age: 18+Code: NCT07277231·Phase 3·Recruiting·Listed Dec 2025Apply to this trial
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumorsfor Advanced Solid TumorSites in Milwaukee +6 more locationsSponsor: BeOne MedicinesSex: All·Age: 18+Code: NCT07226349·Phase 1·Recruiting·Listed Nov 2025Apply to this trial
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)for Metastatic Castration-resistant Prostate CancerSites in Milwaukee +8 more locationsSponsor: Daiichi SankyoSex: Male·Age: 18+Code: NCT07244341·Phase 1·Recruiting·Listed Nov 2025Apply to this trial
A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutationsfor Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)Sites in Milwaukee +8 more locationsSponsor: Regeneron PharmaceuticalsSex: All·Age: All agesCode: NCT05788536·Phase 1, Phase 2·Recruiting·Listed Mar 2023Apply to this trial
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Studyfor Relapsing Remitting Multiple SclerosisSites in Milwaukee +8 more locationsSponsor: SetPoint Medical CorporationSex: All·Age: 22 - 60Code: NCT06796504·Recruiting·Listed Jan 2025Apply to this trial
GORE® ENFORM Biomaterial Product Studyfor Hernia, VentralSites in Milwaukee +6 more locationsSponsor: W.L.Gore & AssociatesSex: All·Age: 18+Code: NCT04718168·Recruiting·Listed Jan 2021Apply to this trial
A Study of BGB-11417 in Participants With Myeloid Malignanciesfor Acute Myeloid LeukemiaSites in Milwaukee +3 more locationsSponsor: BeOne MedicinesSex: All·Age: 18+Code: NCT04771130·Phase 1, Phase 2·Recruiting·Listed Feb 2021Apply to this trial
Asciminib Roll-over Studyfor Chronic Myelogenous LeukemiaSites in Milwaukee +4 more locationsSponsor: Novartis PharmaceuticalsSex: All·Age: 7 - 100Code: NCT04877522·Phase 4·Recruiting·Listed May 2021Apply to this trial
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)for Small Cell Lung CancerDrug: GocatamigSites in Milwaukee +8 more locationsSponsor: Merck Sharp & Dohme LLCSex: All·Age: 18+Code: NCT06780137·Phase 1, Phase 2·Recruiting·Listed Jan 2025Apply to this trial
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancerfor Prostate CancerSites in Milwaukee +6 more locationsSponsor: AmgenSex: Male·Age: 18+Code: NCT06613100·Phase 1·Recruiting·Listed Sep 2024Apply to this trial
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignanciesfor Acute Myelogenous LeukemiaSites in Milwaukee +5 more locationsSponsor: Beijing InnoCare Pharma Tech Co., Ltd.Sex: All·Age: 18+Code: NCT06656494·Phase 1·Recruiting·Listed Oct 2024Apply to this trial
REMASTer: REcurrent Brain Metastases After SRS Trialfor Brain MetastasesSites in Milwaukee +7 more locationsSponsor: Monteris MedicalSex: All·Age: 18+Code: NCT05124912·Recruiting·Listed Nov 2021Apply to this trial
Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.for ArthritisSites in Milwaukee +5 more locationsSponsor: Aptis MedicalSex: All·Age: 18 - 85·Accepts healthy volunteersCode: NCT05796908·Recruiting·Listed Apr 2023Apply to this trial
SPI-1005 in Adults Receiving Cochlear Implantfor Hearing LossSites in Milwaukee +5 more locationsSponsor: Sound Pharmaceuticals, IncorporatedSex: All·Age: 18+Code: NCT06340633·Phase 2·Recruiting·Listed Apr 2024Apply to this trial